A new pancreatic cancer therapy targets sugar molecules on cell surfaces, offering hope where traditional immunotherapies ...

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

The drugmaker said it would launch late-stage trials of the drug after participants lost as much as 20% of their body weight.

By restructuring a common chemotherapy drug, scientists increased its potency by 20,000 times. In a significant step forward for cancer therapy, researchers at Northwestern University have redesigned ...

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

A new approach targets the B-cell pathway with bispecific antibodies, building on decades of research that establishes the ...

Dr. Oz estimated Americans could lose "135 billion pounds" by the midterm elections next year. The administrator of the ...

Known as pre-methylenomycin C lactone, this antibiotic is derived from a model species that’s been studied for nearly 80 ...